Literature DB >> 8748306

Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva.

R C Cubel1, S A Oliveira, D W Brown, B J Cohen, J P Nascimento.   

Abstract

Serum and saliva samples were simultaneously collected from patients with B19 infection. Specimens were collected in a period of 1 to 18 days after the onset of symptoms. Saliva samples were collected with a commercial device, OraSure. The quality of these samples was evaluated by determining the concentration of total immunoglobulin G (IgG) by an enzyme immunoassay. The concentration of IgG in these samples ranged from 4.8 to > 250 mg/liter. B19 infection was confirmed for 20 patients by testing sera in a 1: 100 dilution by an IgM capture enzyme immunoassay (MACEIA) and an IgM capture hemadherence test (MACHAT). Saliva samples from these IgM-positive patients were tested neat by MACEIA and MACHAT. IgM could be detected in 11 of 20 (55%) samples by MACEIA and in 15 of 18 (83%) samples by MACHAT. Serum and saliva samples from a further 17 patients with rash were also tested. All of these specimens were unreactive by both assays. These results show that saliva may be a convenient alternative to serum for the diagnosis of recent B19 infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8748306      PMCID: PMC228763          DOI: 10.1128/jcm.34.1.205-207.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Intrauterine parvovirus infection associated with hydrops fetalis.

Authors:  T Brown; A Anand; L D Ritchie; J P Clewley; T M Reid
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

2.  Parvovirus infections and hypoplastic crisis in sickle-cell anaemia.

Authors:  J R Pattison; S E Jones; J Hodgson; L R Davis; J M White; C E Stroud; L Murtaza
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

3.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

4.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Diagnosis of hepatitis A and B by testing saliva.

Authors:  J V Parry; K R Perry; S Panday; P P Mortimer
Journal:  J Med Virol       Date:  1989-08       Impact factor: 2.327

6.  An outbreak of erythema infectiosum associated with human parvovirus infection.

Authors:  M J Anderson; E Lewis; I M Kidd; S M Hall; B J Cohen
Journal:  J Hyg (Lond)       Date:  1984-08

7.  The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent.

Authors:  M J Anderson; L R Davis; S E Jones; J R Pattison; G R Serjeant
Journal:  J Hyg (Lond)       Date:  1982-04

8.  Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.

Authors:  M M Salimans; M J van Bussel; C S Brown; W J Spaan
Journal:  J Virol Methods       Date:  1992-09       Impact factor: 2.014

9.  Human parvovirus-associated arthritis: a clinical and laboratory description.

Authors:  D M Reid; T M Reid; T Brown; J A Rennie; C J Eastmond
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

10.  Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in São Paulo, Brazil.

Authors:  R S de Azevedo Neto; A Richards; D J Nokes; A S Silveira; B J Cohen; S D Passos; V A de Souza; D W Brown; C S Pannuti; E Massad
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jan-Feb       Impact factor: 2.184

View more
  3 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Use of oral fluid samples for the investigation of outbreaks of human parvovirus B19 infection.

Authors:  Daiana Lima Almada; Arthur Daniel Rocha Alves; Luciane Almeida Amado Leon; Débora Familiar Rodrigues Macedo; Solange Artimos de Oliveira; Marilda Mendonça Siqueira; David Brown; Rita de Cássia Nasser Cubel Garcia
Journal:  Braz J Microbiol       Date:  2022-09-23       Impact factor: 2.214

3.  Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.

Authors:  Jennifer E Cameron; Isaac V Snowhite; Anil K Chaturvedi; Michael E Hagensee
Journal:  Clin Diagn Lab Immunol       Date:  2003-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.